Safinamide protects against amyloid β (Aβ)-induced oxidative stress and cellular senescence in M17 neuronal cells

Alzheimer’s disease (AD) is a neurodegenerative disorder that is pathologically related to oxidative stress and cellular senescence. Safinamide is one of the clinically prescribed monoamine oxidase B (MAOB) inhibitors. It has been reported to possess therapeutic potential in neurological disorders....

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xunhu, Zhang, Ge, Qin, Zhengfang, Yin, Min, Chen, Weiping, Zhang, Yangbo, Liu, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805854/
https://www.ncbi.nlm.nih.gov/pubmed/35001806
http://dx.doi.org/10.1080/21655979.2021.2022262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805854/
https://www.ncbi.nlm.nih.gov/pubmed/35001806
http://dx.doi.org/10.1080/21655979.2021.2022262

Ejemplares similares